0001209191-16-142271.txt : 20160921 0001209191-16-142271.hdr.sgml : 20160921 20160921162154 ACCESSION NUMBER: 0001209191-16-142271 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160920 FILED AS OF DATE: 20160921 DATE AS OF CHANGE: 20160921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOUDREAUX GAIL CENTRAL INDEX KEY: 0001287920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 161895827 MAIL ADDRESS: STREET 1: GENZYME CORP. STREET 2: 500 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-09-20 0 0001000694 NOVAVAX INC NVAX 0001287920 BOUDREAUX GAIL C/O NOVAVAX, INC. 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 1 0 0 0 Common Stock 2016-09-20 4 P 0 100000 1.4485 A 200000 D The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.45, inclusive. The reporting person undertakes to provide Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. /s/ John A. Herrmann III, Attorney-in-Fact 2016-09-21